rs1031919

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_153717.3(EVC):​c.2305-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.731 in 1,612,074 control chromosomes in the GnomAD database, including 432,017 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39628 hom., cov: 33)
Exomes 𝑓: 0.73 ( 392389 hom. )

Consequence

EVC
NM_153717.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00005523
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.05

Publications

13 publications found
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 4-5801942-T-C is Benign according to our data. Variant chr4-5801942-T-C is described in ClinVar as Benign. ClinVar VariationId is 262774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.2305-8T>C splice_region_variant, intron_variant Intron 15 of 20 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.2305-8T>C splice_region_variant, intron_variant Intron 15 of 20 1 NM_153717.3 ENSP00000264956.6 P57679
CRMP1ENST00000506216.5 linkn.1647+23552A>G intron_variant Intron 12 of 12 5
EVCENST00000515113.1 linkn.*135T>C downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.721
AC:
109631
AN:
152034
Hom.:
39592
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.708
Gnomad AMI
AF:
0.844
Gnomad AMR
AF:
0.685
Gnomad ASJ
AF:
0.672
Gnomad EAS
AF:
0.551
Gnomad SAS
AF:
0.812
Gnomad FIN
AF:
0.788
Gnomad MID
AF:
0.675
Gnomad NFE
AF:
0.735
Gnomad OTH
AF:
0.704
GnomAD2 exomes
AF:
0.719
AC:
179567
AN:
249798
AF XY:
0.727
show subpopulations
Gnomad AFR exome
AF:
0.716
Gnomad AMR exome
AF:
0.644
Gnomad ASJ exome
AF:
0.685
Gnomad EAS exome
AF:
0.549
Gnomad FIN exome
AF:
0.783
Gnomad NFE exome
AF:
0.733
Gnomad OTH exome
AF:
0.715
GnomAD4 exome
AF:
0.732
AC:
1068320
AN:
1459922
Hom.:
392389
Cov.:
53
AF XY:
0.734
AC XY:
533351
AN XY:
726242
show subpopulations
African (AFR)
AF:
0.708
AC:
23682
AN:
33438
American (AMR)
AF:
0.650
AC:
28970
AN:
44570
Ashkenazi Jewish (ASJ)
AF:
0.682
AC:
17807
AN:
26114
East Asian (EAS)
AF:
0.537
AC:
21306
AN:
39682
South Asian (SAS)
AF:
0.819
AC:
70540
AN:
86132
European-Finnish (FIN)
AF:
0.776
AC:
41395
AN:
53368
Middle Eastern (MID)
AF:
0.699
AC:
3418
AN:
4890
European-Non Finnish (NFE)
AF:
0.736
AC:
818123
AN:
1111474
Other (OTH)
AF:
0.715
AC:
43079
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
15929
31857
47786
63714
79643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20146
40292
60438
80584
100730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.721
AC:
109717
AN:
152152
Hom.:
39628
Cov.:
33
AF XY:
0.724
AC XY:
53850
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.709
AC:
29404
AN:
41486
American (AMR)
AF:
0.685
AC:
10481
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.672
AC:
2333
AN:
3472
East Asian (EAS)
AF:
0.552
AC:
2844
AN:
5152
South Asian (SAS)
AF:
0.811
AC:
3912
AN:
4824
European-Finnish (FIN)
AF:
0.788
AC:
8358
AN:
10606
Middle Eastern (MID)
AF:
0.668
AC:
195
AN:
292
European-Non Finnish (NFE)
AF:
0.734
AC:
49944
AN:
68000
Other (OTH)
AF:
0.698
AC:
1476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1634
3267
4901
6534
8168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.728
Hom.:
17451
Bravo
AF:
0.708
Asia WGS
AF:
0.678
AC:
2358
AN:
3478
EpiCase
AF:
0.718
EpiControl
AF:
0.722

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Curry-Hall syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.93
DANN
Benign
0.61
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1031919; hg19: chr4-5803669; COSMIC: COSV53830478; COSMIC: COSV53830478; API